Ready to Use Pharmaceutical Packaging: Trends and Opportunities

The ready to use of pharmaceutical primary packaging has emerged as a promising alternative to conventional primary packaging, adding significant value to streamline pharmaceutical fill / finish operations. These packaging components eliminate multiple steps in the overall fill finish manufacturing (mainly washing, sterilizing and preparing containers), thereby, helping improve operational efficiencies in compliance to existing  regulatory standards. Owing to several other benefits offered by medical polymers, RTU container-closure systems have gradually gained popularity in the pharmaceutical industry.


Over 45 companies are actively involved in the development of ready-to-use (RTU) primary packaging products and affiliated processing equipment

The leading companies operating in this research are APG Pharma Packaging, Aptar, Daikyo Seiko, Datwyler, DWK Life Sciences, Ningbo Zhengli Pharmaceutical Packaging, Nuova OMPI (a subsidiary of Stevanato), SCHOTT and West Pharmaceutical Services.

Over 100 ready to use packaging components and processing equipments. Majority of the developers are headquarted in North America.

The pharmaceutical primary packaging market is fragmented, featuring the presence of a large number of established players; a relatively larger proportion of the industry stakeholders are based in Europe.


Currently, there are over 70 commercially available pharmaceutical primary packaging products and close to 50 different equipment systems that can process such container-closures.


In order to cope up with the prevalent and upcoming pharmaceutical trends, the packaging industry is steadily evolving to cater to the changing needs of drug manufacturers.


A number of partnerships have been established in the recent past; in addition, stakeholders have made some strategic acquisitions to strengthen their product portfolios

Various industry and non-industry players are continuously involved signing partnership deals. Over 35% of the deals were focused on the acquisition of players to strengthen there portfolio.

The Ready to Use Pharmaceutical Packaging Market is projected to grow at an annualized rate of 8.74% in the period between 2023 – 2035.


The opportunity is likely to be distributed across different packaging types, with plastic as the preferred material; Asia Pacific market is projected to grow at a relatively faster pace

The market for ready to use primary packaging is fragmented across different segments including packaging components, material used and geography.

To learn more, please click Ready to Use Pharmaceutical Packaging Market. For any queries / suggestions, please do not hesitate to contact us at sales@rootsanalysis.com. You can also download the SAMPLE REPORT on primary packaging by Roots Analysis.

Our Social Media Platform

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com